Found: 29
Select item for more details and to access through your institution.
Whole body magnetic resonance in indolent lymphomas under watchful waiting: The time is now.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Osteonecrosis detected by whole body magnetic resonance in patients with Hodgkin Lymphoma treated by BEACOPP.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Therapeutic Management of Patients with FLT3 + Acute Myeloid Leukemia: Case Reports and Focus on Gilteritinib Monotherapy.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2022, v. 15, p. 393, doi. 10.2147/PGPM.S346688
- By:
- Publication type:
- Article
Whole-body MRI in patients with lymphoma: collateral findings.
- Published in:
- La Radiologia Medica, 2016, v. 121, n. 10, p. 793, doi. 10.1007/s11547-016-0658-x
- By:
- Publication type:
- Article
A phase 2, multicentre, open‐label trial (ACE‐LY‐003) of acalabrutinib in patients with relapsed or refractory marginal zone lymphoma.
- Published in:
- British Journal of Haematology, 2022, v. 199, n. 1, p. 76, doi. 10.1111/bjh.18368
- By:
- Publication type:
- Article
Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study.
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 5, p. 755, doi. 10.1111/bjh.15641
- By:
- Publication type:
- Article
The metronomic all-oral DEVEC is an effective schedule in elderly patients with diffuse large b-cell lymphoma.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 3, p. 548, doi. 10.1007/s10637-019-00769-5
- By:
- Publication type:
- Article
Impact of minimal residual disease response and of status of disease on survival after blinatumomab in B-cell acute lymphoblastic leukemia: results from a real-life study.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 9, p. 3701, doi. 10.1007/s00277-024-05725-9
- By:
- Publication type:
- Article
Bendamustine with or without rituximab for the treatment of heavily pretreated non-Hodgkin's lymphoma patients.
- Published in:
- Annals of Hematology, 2012, v. 91, n. 7, p. 1013, doi. 10.1007/s00277-012-1422-5
- By:
- Publication type:
- Article
Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Correction: Bocci et al. Remarkable Remission Rate and Long-Term Efficacy of Upfront Metronomic Chemotherapy in Elderly and Frail Patients, with Diffuse Large B-Cell Lymphoma. J. Clin. Med. 2022, 11 , 7162.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Remarkable Remission Rate and Long-Term Efficacy of Upfront Metronomic Chemotherapy in Elderly and Frail Patients, with Diffuse Large B-Cell Lymphoma.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 23, p. 7162, doi. 10.3390/jcm11237162
- By:
- Publication type:
- Article
Osteonecrosis in Hodgkin lymphoma treated by BEACOPP.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Real-World Outcome of Treatment with Single-Agent Ibrutinib in Italian Patients with Chronic Lymphocytic Leukemia: Final Results of the EVIdeNCE Study.
- Published in:
- Cancers, 2024, v. 16, n. 6, p. 1228, doi. 10.3390/cancers16061228
- By:
- Publication type:
- Article
Anti-PD1 Consolidation in Patients with Hodgkin Lymphoma at High Risk of Relapse after Autologous Stem Cell Transplantation: A Multicenter Real-Life Study.
- Published in:
- Cancers, 2022, v. 14, n. 23, p. 5846, doi. 10.3390/cancers14235846
- By:
- Publication type:
- Article
The neutrophil to lymphocyte ratio (NLR) and the presence of large nodal mass are independent predictors of early response: A subanalysis of the prospective phase II PET‐2‐adapted HD0607 trial.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 23, p. 8735, doi. 10.1002/cam4.3396
- By:
- Publication type:
- Article
Sorafenib maintenance after allogeneic stem cell transplantation in patients with FLT3+ AML receiving midostaurin during induction and consolidation: a retrospective analysis.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1441254
- By:
- Publication type:
- Article
All-oral metronomic DEVEC schedule in elderly patients with peripheral T cell lymphoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 6, p. 841, doi. 10.1007/s00280-020-04172-3
- By:
- Publication type:
- Article
Predictive value on advance hodgkin lymphoma treatment outcome of end‐of treatment FDG PET/CT in the HD0607 clinical trial.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 3, p. 415, doi. 10.1002/hon.3117
- By:
- Publication type:
- Article
Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real‐life experience.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 1, p. 31, doi. 10.1002/hon.2939
- By:
- Publication type:
- Article
Early serum TARC reduction predicts prognosis in advanced‐stage Hodgkin lymphoma patients treated with a PET‐adapted strategy.
- Published in:
- Hematological Oncology, 2020, v. 38, n. 4, p. 501, doi. 10.1002/hon.2775
- By:
- Publication type:
- Article
Whole-body magnetic resonance imaging (WB-MRI) in lymphoma: State of the art.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Autoimmune haemolytic anaemia in mantle cell lymphoma : an insidious complication associated with leukemic disease.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
The lymphocyte to monocyte ratio improves the IPI-risk definition of diffuse large B-cell lymphoma when rituximab is added to chemotherapy.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 12, p. 1062, doi. 10.1002/ajh.23566
- By:
- Publication type:
- Article
Whole-Body Magnetic Resonance Imaging: Current Role in Patients with Lymphoma.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 6, p. 1007, doi. 10.3390/diagnostics11061007
- By:
- Publication type:
- Article
Allogeneic Stem Cell Transplantation in Refractory Acute Myeloid Leukaemia.
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 9, p. 755, doi. 10.3390/cells13090755
- By:
- Publication type:
- Article
Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses.
- Published in:
- British Journal of Haematology, 2011, v. 152, n. 5, p. 551, doi. 10.1111/j.1365-2141.2010.08485.x
- By:
- Publication type:
- Article
Lenalidomide in Pretreated Patients with Diffuse Large B‐Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice.
- Published in:
- Oncologist, 2019, v. 24, n. 9, p. 1246, doi. 10.1634/theoncologist.2018-0603
- By:
- Publication type:
- Article
Whole-body magnetic resonance imaging and FDG-PET/CT for lymphoma staging: Assessment of patient experience.
- Published in:
- Egyptian Journal of Radiology & Nuclear Medicine, 2017, v. 48, n. 4, p. 1043, doi. 10.1016/j.ejrnm.2017.06.002
- By:
- Publication type:
- Article